InvestorsHub Logo
Followers 33
Posts 2971
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Friday, 04/29/2022 7:22:18 PM

Friday, April 29, 2022 7:22:18 PM

Post# of 170
ASGCT title:

EDIT-202, a Multiplexed CRISPR-Cas12a Gene-Edited iPSC-Derived NK Cell Therapy Has Prolonged Persistence, Promotes High Cytotoxicity, and Enhances In Vivo Tumor Killing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EDIT News